Biopharmaceuticals

New York, USA, September 7, 2026 Insilico Medicine’s AI-driven investigational drug rentosertib has demonstrated potential to reduce measures of...

Seoul, South Korea, September 7, 2026 RZNOMICS Inc., a biopharmaceutical company focused on RNA-based gene therapies, has reported major...

Tel Aviv, Israel, September 4, 2026 Teva Pharmaceutical Industries Ltd. has received an upgrade to BBB- from BB+ for...

Shirley, New York, September 3, 2026 American Regent, Inc. has initiated a voluntary nationwide recall of three lots of...

San Francisco, California, September 3, 2026 Thryv Therapeutics Inc., a clinical-stage biopharmaceutical company developing selective SGK1 inhibitors, has entered...

Wuxi, China, September 2, 2026 Norroy Bioscience has received regulatory clearance from China’s National Medical Products Administration (NMPA) to...

Daejeon, South Korea, September 2, 2026 Alteogen Inc. has entered into an option and license agreement with Novartis to...

Zurich, Switzerland, September 2, 2026 NovaGo Therapeutics, a Swiss clinical-stage biotechnology company developing antibody therapeutics for nerve growth and...

San Diego, California, USA, September 1, 2026 Styx Biotechnologies Inc., a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for...

DUBLIN and BRIDGEWATER, N.J., August 31, 2026 Amarin Corporation plc highlighted new findings from multiple REDUCE-IT® analyses presented at...